Home
Conditions
Urinary Bladder Diseases

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Not Yet Recruiting

Prehabilitation in High-risk Oncologic Surgery

NCT07638410

Conditions: Abdominal Surgery Complications, Adnexal Diseases, Bladder Cancer, +43 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Radio-frequency (RF) Bladder Monitor

NCT07639541

Conditions: Central Nervous System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Centre for Innovative Medicine (CIM) - McGill University Health Centre (MUHC) Montreal, Quebec, Canada

View Trial Details

Not Yet Recruiting

Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma

NCT07639983

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Novel Wearable Transcutaneous Tibial Nerve Stimulation (TTNS) Device in the Treatment of Patients With Overactive Bladder (OAB) and Nocturia

NCT07635251

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations: Qilu Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Efficacy of Probiotics for OAB Patients With Anxiety

NCT07635212

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Qilu Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

NCT07332351

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)

NCT07260162

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations: Institut de Cancérologie de l'Ouest Saint-Herblain, Loire Atlantique, France

View Trial Details

Not Yet Recruiting

Poly-L-Lactic Acid for Vulvovaginal Tissue Regeneration

NCT07544667

Conditions: Cystocele, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Duke Urogynecology, Patterson Place Durham, North Carolina, United States

View Trial Details

Not Yet Recruiting

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

NCT07625527

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations: The Second Hospital of Tianjin Medical University Tianjin, China

General Hospital of Tianjin Medical University Tianjin, China

Tianjin Hospital Tianjin, China

Xingtai People's Hospital Xingtai, China

View Trial Details

Not Yet Recruiting

Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease

NCT07627529

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Corporal Michael J. Crescenz VA Medical Center Philadelphia, Pennsylvania, United States

View Trial Details

Urinary Bladder Diseases

Urinary Bladder Diseases trial results

Related conditions